Boenning Scattergood Reaffirms “Outperform” Rating for Xylem Inc. (XYL)

Boenning Scattergood restated their outperform rating on shares of Xylem Inc. (NYSE:XYL) in a research note released on Tuesday, September 5th.

A number of other analysts have also recently commented on the stock. Cowen and Company restated an outperform rating and set a $70.00 price target (up from $60.00) on shares of Xylem in a research note on Wednesday, August 9th. Oppenheimer Holdings, Inc. upped their price target on shares of Xylem from $60.00 to $66.00 and gave the company an outperform rating in a research note on Wednesday, August 2nd. Barclays PLC upgraded shares of Xylem from an equal weight rating to an overweight rating and upped their price target for the company from $51.00 to $59.00 in a research note on Monday, May 15th. Stifel Nicolaus reiterated a hold rating and issued a $63.00 target price on shares of Xylem in a research note on Tuesday, September 5th. Finally, BMO Capital Markets initiated coverage on shares of Xylem in a research note on Wednesday, June 21st. They issued an outperform rating and a $60.00 target price on the stock. Five equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock has an average rating of Buy and a consensus target price of $59.67.

Shares of Xylem (NYSE:XYL) traded up 1.28% during mid-day trading on Tuesday, hitting $64.75. The company’s stock had a trading volume of 776,095 shares. The company has a 50-day moving average price of $60.96 and a 200-day moving average price of $54.45. The stock has a market cap of $11.63 billion, a PE ratio of 41.80 and a beta of 1.17. Xylem has a 1-year low of $45.60 and a 1-year high of $64.80.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, August 1st. The industrial products company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.57 by $0.02. Xylem had a net margin of 6.58% and a return on equity of 17.26%. The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the firm posted $0.48 earnings per share. The firm’s revenue for the quarter was up 24.9% on a year-over-year basis. Analysts predict that Xylem will post $2.37 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Boenning Scattergood Reaffirms “Outperform” Rating for Xylem Inc. (XYL)” was originally published by BBNS and is the property of of BBNS. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://baseballnewssource.com/markets/boenning-scattergood-reiterates-outperform-rating-for-xylem-inc-xyl/1608352.html.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 20th. Investors of record on Thursday, August 31st were issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 1.11%. The ex-dividend date of this dividend was Tuesday, August 29th. Xylem’s dividend payout ratio is currently 46.45%.

In other Xylem news, Director Steven R. Loranger sold 66,132 shares of the firm’s stock in a transaction on Thursday, June 29th. The shares were sold at an average price of $55.01, for a total value of $3,637,921.32. Following the sale, the director now owns 65,030 shares of the company’s stock, valued at approximately $3,577,300.30. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Kenneth Napolitano sold 9,052 shares of the firm’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $60.16, for a total transaction of $544,568.32. Following the completion of the sale, the insider now directly owns 35,303 shares in the company, valued at approximately $2,123,828.48. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by company insiders.

Several large investors have recently bought and sold shares of the company. Farmers & Merchants Investments Inc. lifted its position in shares of Xylem by 0.7% in the 2nd quarter. Farmers & Merchants Investments Inc. now owns 3,445 shares of the industrial products company’s stock worth $191,000 after purchasing an additional 25 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in shares of Xylem by 0.3% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 13,352 shares of the industrial products company’s stock worth $740,000 after purchasing an additional 39 shares during the period. National Asset Management Inc. lifted its position in shares of Xylem by 0.5% in the 1st quarter. National Asset Management Inc. now owns 8,778 shares of the industrial products company’s stock worth $442,000 after purchasing an additional 48 shares during the period. CIBC Asset Management Inc lifted its position in shares of Xylem by 0.3% in the 2nd quarter. CIBC Asset Management Inc now owns 17,671 shares of the industrial products company’s stock worth $980,000 after purchasing an additional 58 shares during the period. Finally, Page Arthur B lifted its position in shares of Xylem by 0.5% in the 2nd quarter. Page Arthur B now owns 14,420 shares of the industrial products company’s stock worth $798,000 after purchasing an additional 70 shares during the period. 86.43% of the stock is owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Bryce Harper Hoping to Return Monday from Knee Injury
Bryce Harper Hoping to Return Monday from Knee Injury
American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?


Leave a Reply

 
© 2006-2017 BBNS.